The Medical Letter on Drugs and Therapeutics
FROM
ISSUE
1555
September 10, 2018
View Complete Issue         Table of Contents 2019 
A Mometasone-Eluting Sinus Implant (Sinuva) for Nasal Polyps
Subscribers: Log in to read full article.  Not a subscriber?  Subscribe or purchase article.
A Mometasone-Eluting Sinus Implant (Sinuva) for Nasal Polyps
September 10, 2018 (Issue: 1555)
The FDA has approved Sinuva (Intersect ENT), a sinus implant that gradually releases the corticosteroid mometasone furoate over a 90-day period, for treatment of nasal polyps in adults who have had ethmoid sinus surgery. Propel, a sinus implant...more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.

Would you like to read the rest of this article?  Gain access below.

Subscribe
Subscriptions to The Medical Letter on Drugs and Therapeutics include:
  • Print version published and mailed biweekly (26 issues/year)
  • Unlimited online access to current and past issues (1988 - present)
  • Mobile App
  • FREE online per issue CME/CE
Purchase this article:
Title: A Mometasone-Eluting Sinus Implant (Sinuva) for Nasal Polyps
Article code: 1555e
 Electronic, downloadable article - $45


Gain access through your organization
Ask your librarian to consider an Institutional Subscription to The Medical Letter.